The U.S. accounted for about 40% of sales in a $1.4 trillion biopharma market as of 2021, according to research from Morningstar.
Read OriginalESG risks in biopharma
InvestingESG.org
ESG investing is just investing
Republicans Weigh Rolling Back Anti-ESG Law They Passed
Leonard Leo’s Concord Fund Top Funder of Republican AGs Group in 2024 – EXPOSEDbyCMD
More Than a Third of Independent Lennar Shareholders Push Homebuilder for Emissions Targets
Investment in US renewables hit a record $88B last year
Supreme Court: Companies can’t be sued for not disclosing climate risk
Why a Portfolio With Low ESG Risk Can Better Withstand a Market Crisis
Capital One shareholders urged to approve scope 3 target-setting proposal
House GOP spearheads legislation to strike down SEC climate disclosure rule
Louisiana’s flagship university lets oil firms influence research for a price
Why Companies Need to Lobby for Climate Policy
Footer
About Investing ESG
InvestingESG is an educational resource from leading shareholder advocacy organization, As You Sow. We provide financial professionals, ESG practitioners, the media, and everyday investors with trusted resources to stay above the noise and focus on building a safe, just, and sustainable world for all.
Leave a Reply